Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA pharmacokinetics in early-stage PBC and healthy volunteers
NL-OMON31024Not yet recruiting
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Mar 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ursodeoxycholic acid in primary biliary cholangitis (PBC) (2 arms), sponsored by Dr. Falk Pharma GmbH. Primary endpoints: Safety, Pharmacokinetic parameters and 2 more. Planned start Mar 2007; status: not yet recruiting.
02
Drugs
ursodeoxycholic acid
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NL-OMON31024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31024.